APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Therapeutic Protein Industry Growth and Trends Forecast to 2032

Report ID 174040780122 December 2025104 pages

Choose your research edition.

Industry ResearchTherapeutic Protein Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Protein Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Therapeutic Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Protein Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Protein Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Therapeutic Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Therapeutic Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Therapeutic Protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Therapeutic Protein include Eli Lilly, Baxter International, Amgen, AstraZeneca, GeneScience Pharmaceuticals, Generex Biotechnology, Genentech, Diasome Pharmaceuticals and Chugai Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Therapeutic Protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Therapeutic Protein market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Therapeutic Protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Therapeutic Protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Therapeutic Protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Therapeutic Protein Market by Company

Eli Lilly

Baxter International

Amgen

AstraZeneca

GeneScience Pharmaceuticals

Generex Biotechnology

Genentech

Diasome Pharmaceuticals

Chugai Pharmaceutical

Boehringer Ingelheim

Abbott Laboratories

Therapeutic Protein Segment by Type

Insulin

Human Growth Hormone

Blood Clotting Factors

Interferon

Monoclonal Antibodies

Follicle Stimulating Hormone

Erythropoietin

Therapeutic Protein Segment by Application

Pharmaceutical Companies

Healthcare Service Providers

Research Organizations

Academic Research Institutes

Therapeutic Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Therapeutic Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Table 2. Major Company of Human Growth Hormone Table 3. Major Company of Blood Clotting Factors Table 4. Major Company of Interferon Table 5. Major Company of Monoclonal Antibodies Table 6. Major Company of Follicle Stimulating Hormone Table 7. Major Company of Erythropoietin Table 8. Global Therapeutic Protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Therapeutic Protein Sales by Type (2021-2026) & (k tons) Table 10. Global Therapeutic Protein Sales Market Share in Volume by Type (2021-2026) Table 11. Global Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 12. Global Therapeutic Protein Sales Market Share in Value by Type (2021-2026) Table 13. Global Therapeutic Protein Price by Type (2021-2026) & (US$/ton) Table 14. Global Therapeutic Protein Sales by Type (2027-2032) & (k tons) Table 15. Global Therapeutic Protein Sales Market Share in Volume by Type (2027-2032) Table 16. Global Therapeutic Protein Sales by Type (2027-2032) & (US$ Million) Table 17. Global Therapeutic Protein Sales Market Share in Value by Type (2027-2032) Table 18. Global Therapeutic Protein Price by Type (2027-2032) & (US$/ton) Table 19. North America Therapeutic Protein Sales by Type (2021-2026) & (k tons) Table 20. North America Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Therapeutic Protein Sales by Type (2021-2026) & (k tons) Table 22. Europe Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Therapeutic Protein Sales by Type (2021-2026) & (k tons) Table 24. Asia-Pacific Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Therapeutic Protein Sales by Type (2021-2026) & (k tons) Table 26. Latin America Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Therapeutic Protein Sales by Type (2021-2026) & (k tons) Table 28. Middle East and Africa Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 29. Therapeutic Protein Industry Trends Table 30. Therapeutic Protein Industry Drivers Table 31. Therapeutic Protein Industry Opportunities and Challenges Table 32. Therapeutic Protein Industry Restraints Table 33. Global Therapeutic Protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Therapeutic Protein Revenue Market Share by Company (2021-2026) Table 35. Global Therapeutic Protein Sales by Company (2021-2026) & (k tons) Table 36. Global Therapeutic Protein Sales Share by Company (2021-2026) Table 37. Global Therapeutic Protein Market Price by Company (2021-2026) & (US$/ton) Table 38. Global Therapeutic Protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Therapeutic Protein Major Company Production Sites and Headquarters Table 40. Global Therapeutic Protein Company, Product Type & Application Table 41. Global Therapeutic Protein Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Therapeutic Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Therapeutic Protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Therapeutic Protein Sales by Region (2021-2026) & (k tons) Table 46. Global Therapeutic Protein Sales Market Share in Volume by Region (2021-2026) Table 47. Global Therapeutic Protein Sales by Region (2021-2026) & (US$ Million) Table 48. Global Therapeutic Protein Sales Market Share in Value by Region (2021-2026) Table 49. Global Therapeutic Protein Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 50. Global Therapeutic Protein Sales by Region (2027-2032) & (k tons) Table 51. Global Therapeutic Protein Sales Market Share in Volume by Region (2027-2032) Table 52. Global Therapeutic Protein Sales by Region (2027-2032) & (US$ Million) Table 53. Global Therapeutic Protein Sales Market Share in Value by Region (2027-2032) Table 54. Global Therapeutic Protein Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 55. Global Therapeutic Protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Therapeutic Protein Sales by Application (2021-2026) & (k tons) Table 57. Global Therapeutic Protein Sales Market Share in Volume by Application (2021-2026) Table 58. Global Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 59. Global Therapeutic Protein Sales Market Share in Value by Application (2021-2026) Table 60. Global Therapeutic Protein Price by Application (2021-2026) & (US$/ton) Table 61. Global Therapeutic Protein Sales by Application (2027-2032) & (k tons) Table 62. Global Therapeutic Protein Sales Market Share in Volume by Application (2027-2032) Table 63. Global Therapeutic Protein Sales by Application (2027-2032) & (US$ Million) Table 64. Global Therapeutic Protein Sales Market Share in Value by Application (2027-2032) Table 65. Global Therapeutic Protein Price by Application (2027-2032) & (US$/ton) Table 66. North America Therapeutic Protein Sales by Application (2021-2026) & (k tons) Table 67. North America Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Therapeutic Protein Sales by Application (2021-2026) & (k tons) Table 69. Europe Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Therapeutic Protein Sales by Application (2021-2026) & (k tons) Table 71. Asia-Pacific Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Therapeutic Protein Sales by Application (2021-2026) & (k tons) Table 73. Latin America Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Therapeutic Protein Sales by Application (2021-2026) & (k tons) Table 75. Middle East and Africa Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 76. Eli Lilly Company Information Table 77. Eli Lilly Business Overview Table 78. Eli Lilly Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Eli Lilly Therapeutic Protein Product Portfolio Table 80. Eli Lilly Recent Development Table 81. Baxter International Company Information Table 82. Baxter International Business Overview Table 83. Baxter International Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Baxter International Therapeutic Protein Product Portfolio Table 85. Baxter International Recent Development Table 86. Amgen Company Information Table 87. Amgen Business Overview Table 88. Amgen Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Amgen Therapeutic Protein Product Portfolio Table 90. Amgen Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. AstraZeneca Therapeutic Protein Product Portfolio Table 95. AstraZeneca Recent Development Table 96. GeneScience Pharmaceuticals Company Information Table 97. GeneScience Pharmaceuticals Business Overview Table 98. GeneScience Pharmaceuticals Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. GeneScience Pharmaceuticals Therapeutic Protein Product Portfolio Table 100. GeneScience Pharmaceuticals Recent Development Table 101. Generex Biotechnology Company Information Table 102. Generex Biotechnology Business Overview Table 103. Generex Biotechnology Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 104. Generex Biotechnology Therapeutic Protein Product Portfolio Table 105. Generex Biotechnology Recent Development Table 106. Genentech Company Information Table 107. Genentech Business Overview Table 108. Genentech Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 109. Genentech Therapeutic Protein Product Portfolio Table 110. Genentech Recent Development Table 111. Diasome Pharmaceuticals Company Information Table 112. Diasome Pharmaceuticals Business Overview Table 113. Diasome Pharmaceuticals Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 114. Diasome Pharmaceuticals Therapeutic Protein Product Portfolio Table 115. Diasome Pharmaceuticals Recent Development Table 116. Chugai Pharmaceutical Company Information Table 117. Chugai Pharmaceutical Business Overview Table 118. Chugai Pharmaceutical Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 119. Chugai Pharmaceutical Therapeutic Protein Product Portfolio Table 120. Chugai Pharmaceutical Recent Development Table 121. Boehringer Ingelheim Company Information Table 122. Boehringer Ingelheim Business Overview Table 123. Boehringer Ingelheim Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 124. Boehringer Ingelheim Therapeutic Protein Product Portfolio Table 125. Boehringer Ingelheim Recent Development Table 126. Abbott Laboratories Company Information Table 127. Abbott Laboratories Business Overview Table 128. Abbott Laboratories Therapeutic Protein Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 129. Abbott Laboratories Therapeutic Protein Product Portfolio Table 130. Abbott Laboratories Recent Development Table 131. North America Therapeutic Protein Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 132. North America Therapeutic Protein Sales by Country (2021-2026) & (k tons) Table 133. North America Therapeutic Protein Sales Market Share by Country (2021-2026) Table 134. North America Therapeutic Protein Sales Forecast by Country (2027-2032) & (k tons) Table 135. North America Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 136. North America Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Therapeutic Protein Market Share by Country (2021-2026) Table 139. North America Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 141. Europe Therapeutic Protein Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 142. Europe Therapeutic Protein Sales by Country (2021-2026) & (k tons) Table 143. Europe Therapeutic Protein Sales Market Share by Country (2021-2026) Table 144. Europe Therapeutic Protein Sales Forecast by Country (2027-2032) & (k tons) Table 145. Europe Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Therapeutic Protein Market Share by Country (2021-2026) Table 149. Europe Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Therapeutic Protein Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Therapeutic Protein Sales by Country (2021-2026) & (k tons) Table 153. Asia-Pacific Therapeutic Protein Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Therapeutic Protein Sales Forecast by Country (2027-2032) & (k tons) Table 155. Asia-Pacific Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Therapeutic Protein Market Share by Country (2021-2026) Table 159. Asia-Pacific Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 161. Latin America Therapeutic Protein Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 162. Latin America Therapeutic Protein Sales by Country (2021-2026) & (k tons) Table 163. Latin America Therapeutic Protein Sales Market Share by Country (2021-2026) Table 164. Latin America Therapeutic Protein Sales Forecast by Country (2027-2032) & (k tons) Table 165. Latin America Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Therapeutic Protein Market Share by Country (2021-2026) Table 169. Latin America Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Therapeutic Protein Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Therapeutic Protein Sales by Country (2021-2026) & (k tons) Table 173. Middle East and Africa Therapeutic Protein Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Therapeutic Protein Sales Forecast by Country (2027-2032) & (k tons) Table 175. Middle East and Africa Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Therapeutic Protein Market Share by Country (2021-2026) Table 179. Middle East and Africa Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Therapeutic Protein Distributors List Table 184. Therapeutic Protein Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Therapeutic Protein Image Figure 2. Global Therapeutic Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Protein Sales (2021-2032) & (k tons) Figure 5. Insulin Image Figure 6. Global Insulin Sales YoY Growth (2021-2032) & (k tons) Figure 7. Human Growth Hormone Image Figure 8. Global Human Growth Hormone Sales YoY Growth (2021-2032) & (k tons) Figure 9. Blood Clotting Factors Image Figure 10. Global Blood Clotting Factors Sales YoY Growth (2021-2032) & (k tons) Figure 11. Interferon Image Figure 12. Global Interferon Sales YoY Growth (2021-2032) & (k tons) Figure 13. Monoclonal Antibodies Image Figure 14. Global Monoclonal Antibodies Sales YoY Growth (2021-2032) & (k tons) Figure 15. Follicle Stimulating Hormone Image Figure 16. Global Follicle Stimulating Hormone Sales YoY Growth (2021-2032) & (k tons) Figure 17. Erythropoietin Image Figure 18. Global Erythropoietin Sales YoY Growth (2021-2032) & (k tons) Figure 19. Global Therapeutic Protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Therapeutic Protein Market Share by Type 2025 VS 2032 Figure 21. North America Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 22. North America Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 23. Europe Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 24. Europe Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 27. Latin America Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Therapeutic Protein Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Pharmaceutical Companies Image Figure 34. Global Pharmaceutical Companies Sales YoY Growth (2021-2032) & (k tons) Figure 35. Healthcare Service Providers Image Figure 36. Global Healthcare Service Providers Sales YoY Growth (2021-2032) & (k tons) Figure 37. Research Organizations Image Figure 38. Global Research Organizations Sales YoY Growth (2021-2032) & (k tons) Figure 39. Academic Research Institutes Image Figure 40. Global Academic Research Institutes Sales YoY Growth (2021-2032) & (k tons) Figure 41. Global Therapeutic Protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Therapeutic Protein Market Share by Application 2025 VS 2032 Figure 43. North America Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 44. North America Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 45. Europe Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 46. Europe Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 49. Latin America Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 53. North America Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. North America Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Europe Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 62. Asia-Pacific Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 66. Latin America Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 70. Middle East and Africa Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Therapeutic Protein Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Therapeutic Protein Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • Human Growth Hormone
  • Blood Clotting Factors
  • Interferon
  • Monoclonal Antibodies
  • Follicle Stimulating Hormone
  • Erythropoietin
Applications
  • Pharmaceutical Companies
  • Healthcare Service Providers
  • Research Organizations
  • Academic Research Institutes
Companies covered
  • Eli Lilly
  • Baxter International
  • Amgen
  • AstraZeneca
  • GeneScience Pharmaceuticals
  • Generex Biotechnology
  • Genentech
  • Diasome Pharmaceuticals
  • Chugai Pharmaceutical
  • Boehringer Ingelheim
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Therapeutic Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Therapeutic Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Therapeutic Protein Market by Type
  6. 1.3.1 Insulin
  7. 1.3.2 Human Growth Hormone
  8. 1.3.3 Blood Clotting Factors
  9. 1.3.4 Interferon
  10. 1.3.5 Monoclonal Antibodies
  11. 1.3.6 Follicle Stimulating Hormone
  12. 1.3.7 Erythropoietin
  13. 1.4 Global Therapeutic Protein Market Size by Type
  14. 1.4.1 Global Therapeutic Protein Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Therapeutic Protein Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Therapeutic Protein Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Therapeutic Protein Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Therapeutic Protein Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Therapeutic Protein Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Therapeutic Protein Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Therapeutic Protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Therapeutic Protein Industry Trends
  2. 2.2 Therapeutic Protein Industry Drivers
  3. 2.3 Therapeutic Protein Industry Opportunities and Challenges
  4. 2.4 Therapeutic Protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Therapeutic Protein Revenue (2021-2026)
  2. 3.2 Global Top Players by Therapeutic Protein Sales (2021-2026)
  3. 3.3 Global Top Players by Therapeutic Protein Price (2021-2026)
  4. 3.4 Global Therapeutic Protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Therapeutic Protein Major Company Production Sites & Headquarters
  6. 3.6 Global Therapeutic Protein Company, Product Type & Application
  7. 3.7 Global Therapeutic Protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Therapeutic Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Therapeutic Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Therapeutic Protein Tier 1, Tier 2, and Tier 3
4 Therapeutic Protein Regional Status and Outlook
  1. 4.1 Global Therapeutic Protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Therapeutic Protein Historic Market Size by Region
  3. 4.2.1 Global Therapeutic Protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Therapeutic Protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Therapeutic Protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Therapeutic Protein Forecasted Market Size by Region
  7. 4.3.1 Global Therapeutic Protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Therapeutic Protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Therapeutic Protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Therapeutic Protein by Application
  1. 5.1 Therapeutic Protein Market by Application
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Healthcare Service Providers
  4. 5.1.3 Research Organizations
  5. 5.1.4 Academic Research Institutes
  6. 5.2 Global Therapeutic Protein Market Size by Application
  7. 5.2.1 Global Therapeutic Protein Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Therapeutic Protein Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Therapeutic Protein Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Therapeutic Protein Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Therapeutic Protein Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Therapeutic Protein Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Therapeutic Protein Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Therapeutic Protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly
  2. 6.1.1 Eli Lilly Company Information
  3. 6.1.2 Eli Lilly Business Overview
  4. 6.1.3 Eli Lilly Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly Therapeutic Protein Product Portfolio
  6. 6.1.5 Eli Lilly Recent Developments
  7. 6.2 Baxter International
  8. 6.2.1 Baxter International Company Information
  9. 6.2.2 Baxter International Business Overview
  10. 6.2.3 Baxter International Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter International Therapeutic Protein Product Portfolio
  12. 6.2.5 Baxter International Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Therapeutic Protein Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Therapeutic Protein Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 GeneScience Pharmaceuticals
  26. 6.5.1 GeneScience Pharmaceuticals Company Information
  27. 6.5.2 GeneScience Pharmaceuticals Business Overview
  28. 6.5.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GeneScience Pharmaceuticals Therapeutic Protein Product Portfolio
  30. 6.5.5 GeneScience Pharmaceuticals Recent Developments
  31. 6.6 Generex Biotechnology
  32. 6.6.1 Generex Biotechnology Company Information
  33. 6.6.2 Generex Biotechnology Business Overview
  34. 6.6.3 Generex Biotechnology Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Generex Biotechnology Therapeutic Protein Product Portfolio
  36. 6.6.5 Generex Biotechnology Recent Developments
  37. 6.7 Genentech
  38. 6.7.1 Genentech Company Information
  39. 6.7.2 Genentech Business Overview
  40. 6.7.3 Genentech Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Genentech Therapeutic Protein Product Portfolio
  42. 6.7.5 Genentech Recent Developments
  43. 6.8 Diasome Pharmaceuticals
  44. 6.8.1 Diasome Pharmaceuticals Company Information
  45. 6.8.2 Diasome Pharmaceuticals Business Overview
  46. 6.8.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Diasome Pharmaceuticals Therapeutic Protein Product Portfolio
  48. 6.8.5 Diasome Pharmaceuticals Recent Developments
  49. 6.9 Chugai Pharmaceutical
  50. 6.9.1 Chugai Pharmaceutical Company Information
  51. 6.9.2 Chugai Pharmaceutical Business Overview
  52. 6.9.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chugai Pharmaceutical Therapeutic Protein Product Portfolio
  54. 6.9.5 Chugai Pharmaceutical Recent Developments
  55. 6.10 Boehringer Ingelheim
  56. 6.10.1 Boehringer Ingelheim Company Information
  57. 6.10.2 Boehringer Ingelheim Business Overview
  58. 6.10.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boehringer Ingelheim Therapeutic Protein Product Portfolio
  60. 6.10.5 Boehringer Ingelheim Recent Developments
  61. 6.11 Abbott Laboratories
  62. 6.11.1 Abbott Laboratories Company Information
  63. 6.11.2 Abbott Laboratories Business Overview
  64. 6.11.3 Abbott Laboratories Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Abbott Laboratories Therapeutic Protein Product Portfolio
  66. 6.11.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Therapeutic Protein Sales by Country
  2. 7.1.1 North America Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Therapeutic Protein Sales by Country (2021-2026)
  4. 7.1.3 North America Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Therapeutic Protein Market Size by Country
  6. 7.2.1 North America Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Therapeutic Protein Market Size by Country (2021-2026)
  8. 7.2.3 North America Therapeutic Protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Therapeutic Protein Sales by Country
  2. 8.1.1 Europe Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Therapeutic Protein Sales by Country (2021-2026)
  4. 8.1.3 Europe Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Therapeutic Protein Market Size by Country
  6. 8.2.1 Europe Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Therapeutic Protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Therapeutic Protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Therapeutic Protein Sales by Country
  2. 9.1.1 Asia-Pacific Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Therapeutic Protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Therapeutic Protein Market Size by Country
  6. 9.2.1 Asia-Pacific Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Therapeutic Protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Therapeutic Protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Therapeutic Protein Sales by Country
  2. 10.1.1 South America Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Therapeutic Protein Sales by Country (2021-2026)
  4. 10.1.3 South America Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Therapeutic Protein Market Size by Country
  6. 10.2.1 South America Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Therapeutic Protein Market Size by Country (2021-2026)
  8. 10.2.3 South America Therapeutic Protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Therapeutic Protein Sales by Country
  2. 11.1.1 Middle East and Africa Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Therapeutic Protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Therapeutic Protein Market Size by Country
  6. 11.2.1 Middle East and Africa Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Therapeutic Protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Therapeutic Protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Therapeutic Protein Value Chain Analysis
  2. 12.1.1 Therapeutic Protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Therapeutic Protein Production Mode & Process
  7. 12.2 Therapeutic Protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Therapeutic Protein Distributors
  10. 12.2.3 Therapeutic Protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst